Skip to main content

Table 3 Antimicrobial resistance among 138 human C. jejun i isolates from Thailand (2001-2003)

From: PFGE, Lior serotype, and antimicrobial resistance patterns among Campylobacter jejuni isolated from travelers and US military personnel with acute diarrhea in Thailand, 1998-2003

Antimicrobial

Percentage of resistant isolates (number of isolates)

 

Phitsanulok 2001 (n= 54)

Bangkok 2001-2002 (n= 46)

Sakaew 2002 (n= 15)

Pranburi 2003 (n= 23)

p-value *

Nalidixic acid

96.2% (52)

93.5% (43)

86.6% (13)

100.0% (23)

NS

Ciprofloxacin

96.2% (52)

87.0% (40)

86.6% (13)

91.3% (21)

NS

Erythromycin

0.0% (0)

6.5% (3)

0.0% (0)

0.0% (0)

NS

Azithromycin

0.0% (0)

6.5% (3)

0.0% (0)

0.0% (0)

NS

Tetracycline

90.7% (49)

76.0% (35)

86.6% (13)

69.5% (16)

NS

Trimethoprim-sulfamethoxazole

90.7% (49)

58.7% (27)

26.7% (4)

0.0% (0)

<0.001

Ampicillin

31.5% (17)

30.4% (14)

60.0% (9)

8.7% (2)

<0.05

Kanamycin

0.0% (0)

2.2% (1)

20.0% (3)

21.8% (5)

<0.001

Sulfisoxazole

0.0% (0)

10.9% (5)

0.0% (0)

0.0% (0)

NA

Neomycin

0.0% (0)

2.2% (1)

1.7% (1)

1.7% (1)

NA

Streptomycin

0.0% (0)

0.0% (0)

1.7% (1)

0.0% (0)

NA

Gentamicin

0.0% (0)

0.0% (0)

0.0% (0)

0.0% (0)

NA

Colistin

0.0% (0)

0.0% (0)

0.0% (0)

0.0% (0)

NA

Chloramphenicol

0.0% (0)

0.0% (0)

0.0% (0)

0.0% (0)

NA

Cephalothin

100.0% (52)

100.0% (60)

100.0% (15)

100.0% (23)

NA

  1. * Pearson chi-square Monte Carlo (two-tailed); NS, non-significant; NA, not applicable